Nursing of children patients with Alagille syndrome

Xiao-ying SUN,Xiao-fang LOU

DOI: https://doi.org/10.3760/cma.j.issn.1672-7088.2010.08.021

2010-01-01

Abstract:Alagille综合征又称先天性肝脏小叶间胆管缺乏综合征(Alagille syndrome,AGS).Alagille综合征是一种可累及肝脏、心脏、骨骼、眼睛和颜面等多系统或器官的显性遗传疾病.最初由Alagille[1]描述其症状并发表于英文杂志而得名。

What problem does this paper attempt to address?

Advances in the Research of Molecular Genetics of Alagille Syndrome

GAO Hui,QI Ming

DOI: https://doi.org/10.3760/cma.j.issn.1673-4386.2008.05.018

2008-01-01

Abstract:Alagille syndrome (AGS) is an autosomal dominant heritable complex multisystem disorder involving primarily the liver, heart, eyes, facies, and skeleton. Mortality is approximately 10%-20%, with vascular accidents, cardiac disease, and liver disease accounting for most of the deaths. There is no effective therapy at present. With the rapid development of molecular genetics, mutations of JAG1 gene and Notch2 gene have been found to be associated with AGS. This paper reviews the researches and the latest progress in molecular genetics about AGS.
Clinical, pathological and genetic characteristics of 17 unrelated children with Alagille Syndrome

Jianguo Yan,Yuanzhi Huang,Lili Cao,Yi Dong,Zhiqiang Xu,Fuchuan Wang,Yinjie Gao,Danni Feng and Min Zhang

DOI: https://doi.org/10.1186/s12887-024-04973-y

2024-08-23

BMC Pediatrics

Abstract:Alagille syndrome (ALGS) is a multisystem genetic disorder frequently characterized by hepatic manifestations. This study analyzed the clinical, pathological, and molecular genetic features of ALGS to improve the efficiency of clinical diagnosis.

pediatrics
A Chinese Girl Molecularly Diagnosed with Alagille Syndrome.

Fu-Bang Li,Jie Chen,Jin-Dan Yu,Hui Gao,Ming Qi

DOI: https://doi.org/10.1007/s12519-010-0226-8

2010-01-01

World Journal of Pediatrics

Abstract:Alagille syndrome (AGS) is a rare or fatal disease affecting multiple systems including the liver, heart, eyes, skeleton and face. It has been considered a genetically heterogeneous disorder of the Notch signaling pathway.
Targeted Sequencing and RNA Assay Reveal a Noncanonical JAG1 Splicing Variant Causing Alagille Syndrome.

Yiyao Chen,Xueli Liu,Songchang Chen,Junyu Zhang,Chenming Xu

DOI: https://doi.org/10.3389/fgene.2019.01363

IF: 3.7

2020-01-01

Frontiers in Genetics

Abstract:Alagille syndrome (ALGS), as known as congenital arteriohepatic dysplasia, is a rare autosomal dominant multi-systemic disorder. Mutations in JAG1 or more rarely NOTCH2 have been reported as the cause of ALGS. In this study, a 5-year old girl with typical ALGS feature and her pregnant mother came to our reproductive genetics clinic for counseling. We aimed to clarify the genetic diagnosis and provide prenatal genetic diagnosis for the pregnant. Next generation sequencing (NGS)-based multigene panel was used to identify pathogenic variant of the proband. Then the candidate variant was verified by using Sanger sequencing. RNA assay was performed to clarify splicing effect of the candidate variant. Amniocentesis, karyotyping, and Sanger sequencing were performed for prenatal testing. We found a novel de novo noncanonical JAG1 splicing variant (c.2917-8C > A) in the proband. Peripheral blood RNA assay suggested that the mutant transcript might escape nonsense-mediated messenger RNA (mRNA) decay (NMD) and encode a C-terminal truncated protein. Information of the variant has resulted in a successful prenatal diagnosis of the fetus. Our results clarified the genetic diagnosis of an ALGS patient and ensured utility of prenatal genetic testing.
Clinical Analysis of Pediatric Liver Transplantation for Alagille Syndrome

Shen Conghuan,Ma Ensi,Tao Yifeng,Li Ruidong,Ma Zhenyu,Zhang Quanbao,Li Jianhua,Wang Zhengxin

DOI: https://doi.org/10.3877/cma.j.issn.1674-3903.2020.01.008

2020-01-01

Abstract:Objective To investigate the clinical features of Alagille syndrome (AGS) and the efficacy and prognosis of liver transplantation in the treatment of AGS. Methods The clinical data of 6 children with AGS who received liver transplantation in the Huashan Hospital Affiliated to Fudan University from April 2015 to March 2019 were analyzed retrospectively. The median age was 15 months (6 months to 39 months). The mean preoperative pediatric end-stage liver disease score was (21±9). All of them had jaundice, pruritus and special facial features. JAG1 gene mutation was identified by gene diagnosis before operation. Four children received left lateral lobe living donor liver transplantation, and other 2 children received standard orthotopic liver transplantation. Results All the operations were successfully completed. The 6 recipients were followed for 12 months (3-50 months) up to July 2019. The recipients and grafts were all normal with no acute hepatic failure, vascular complications or rejection during follow-up period. Symptoms such as jaundice and itching subsided achived relief, and the volume of the yellow tumor gradually decreased to disappear. The function of liver grafts was normal, and the growth and development improved. One recipient developed cholangioentelangeal stenosis and intrahepatic bile duct dilatation 1 week after transplantation, and he was cured after receiving biliary anastomosis 1 month after operation. Two cases had infection related complications, 1 was eosinophilic gastroenteritis with EBV infection and the other was CMV infection, all of which were cured. The Z-values of height and body weight of 6 recipients were [- 3.0 (-1.97~-3.90)] and [-3.1(-2.38~-3.40)], (-3.0±0.6) and (-1.6±0.8) before and 1 month after transplantation, respectively, the differences were statistically significant (Z=2.201, t=4.590, P all <0.05); alanine aminotransferase, total bilirubin and cholesterol were (680±481) and (37±16) U/L, (300±165) and (17±11) μmmol / L, (16.5±9.7) and (1.3±0.6) U/L, respectively. The difference was statistically significant (t=3.119, 4.316 and 3.984, P all <0.05). Conclusions Liver transplantation is effective for the treatment of AGS, which can achieve favourable prognosis for children with ineffective medical treatment. Key words: Alagille syndrome; Pediatric liver transplantation; Therapeutic benefit analysis
Clinical and pathological characteristics of Alagille syndrome in Chinese children

Jian-She Wang,Xiao-Hong Wang,Qi-Rong Zhu,Zhong-Lin Wang,Xi-Qi Hu,Shan Zheng

DOI: https://doi.org/10.1007/s12519-008-0051-5

2008-01-01

World Journal of Pediatrics

Abstract:Background Alagille syndrome (AS) is regarded as the most common cause of chronic cholestasis in childhood associated with specific phenotypic features in western countries. This study was undertaken to investigate the significance of AS in Chinese children with chronic cholestasis and to describe its clinical and histological features. Methods From October 2004 to January 2007, 157 children who presented with conjugated jaundice from less than 3 months of age were admitted to a tertiary hospital in Shanghai. Investigations of the heart, spine, eyes and kidneys were conducted in 13 children who experienced prolonged cholestasis beyond 1 year of age after exclusion of biliary atresia and familial progressive intrahepatic cholestasis type 1 or 2. In patients with interlobular bile duct paucity, AS was diagnosed if 3 or more of the following 5 major features were present: cardiac murmur, posterior embryotoxon, butterfly-like vertebrae, renal abnormalities and characteristic faces. In patients without interlobular bile duct paucity or who did not receive liver biopsy, 4 or more features were required for the diagnosis. Results Of the 13 children, 6 were diagnosed with AS at ages ranging from 1 year and 7 months to 3 years and 11 months. Jaundice was noticed in early infancy and then pruritus developed in all the 6 patients, of whom 5 presented with acholic stool and 4 had been misdiagnosed as having presumed biliary atresia by hepatobiliary scintigraphy or laparoscopic cholangiography. Biochemical examinations demonstrated increased concentration of total bile acid and hyperlipidemia. Interlobular bile duct paucity was demonstrated histologically in 5 patients who received liver biopsy. Vertebral abnormalities, heart murmur, characteristic faces and failure to thrive were found in all the 6 patients. Two patients had evidence of renal involvement. Micropenis, empty scrotum, and gall stone were seen in 1 patient. Conclusion AS is also an important cause of prolonged cholestasis in Chinese children. It is difficult to differentiate AS from biliary atresia. Liver biopsy and spine X-ray may be helpful in the early detection of AS.
[Identification of a Novel JAG1 Mutation in a Family Affected by Alagille Syndrome].

Ying Cheng,Shu-Tao Zhao,Li Guo,Mei Deng,Qing Zhou,Yuan-Zong Song

DOI: https://doi.org/10.7499/j.issn.1008-8830.2016.11.015

2016-01-01

Abstract:Alagille syndrome (ALGS) is an autosomal dominant disorder which is mainly caused by JAG1 gene mutation and can affect multiple systems including the liver, heart, eyes, skeleton and face. This paper reports the clinical and genetic features of an ALGS patient. A 2-year-and-9-month-old boy was referred to the hospital with the complaint of abnormal liver function and heart murmur discovered over two years. Jaundice of the skin and sclera was not observed. The child had a prominent forehead, left esotropia, depressed nasal bridge and micromandible. The two lungs were clear on auscultation, but a systolic cardiac murmur of grade 2/6 could be heard between the 2nd and 3rd intercostal space at the left sternal border. Neither abdominal distension nor enlarged liver or spleen was discovered. X-ray radiography uncovered butterfly malformation of the 6th and 8th thoracic vertebrae. Serum biochemistry analysis revealed elevation of total bile acids, bilirubin and transaminases. Based on the clinical characteristics and the consultation opinion of the ophthalmologist, the child was diagnosed to have ALGS with Duane retraction syndrome. DNA direct sequencing detected a novel JAG1 mutation c.2419delG(p.Glu807AsnfsX819) in the child. Symptomatic and supportive therapy was performed thereafter and clinical follow-up was conducted until he was 4 years and 2 months. In the follow-up visits, his general condition remained stable, but the facial malformations, left esotropia, cardiac murmur and abnormal liver function persistend. The long-term outcome needed to be observed.
The Curious Case of Alagille Syndrome: A Case Report With NANDA-I Classification, NIC, and NOC Linkage to the Patient Care Plan

Anjali Arora,Mini George

DOI: https://doi.org/10.1097/SGA.0000000000000755

Abstract:Alagille syndrome is a rare and complex pleiotropic multisystem disorder caused by an autosomal dominant genetic mutation of JAG1 (90%) and NOTCH2 (1%-2%) genes located on the short arm of chromosome 20. This case is reported as per the CA se RE ports (CARE) guidelines (2013). A 14-year-old boy who is a known case of chronic cholestatic liver disease of neonatal onset, was diagnosed with Alagille syndrome as evident from a NOTCH 2 mutation in genetic analysis and paucity of intrahepatic bile ducts on biopsy. He presented with portal hypertension, growth failure, and persistent hyperbilirubinemia. This case highlights the gamut of multisystem dysfunctions faced by this child. He is currently on conservative management and worked up for liver transplantation. The condition is often rare and challenging due to the multisystem pathogenesis. Thus, the nursing care is also multifaceted. This case study identified relevant North American Nursing Diagnosis Association (NANDA) Classification, Nursing Interventions Classification (NIC), and Nursing Outcomes Classification (NOC) concepts to describe care of children with Alagille syndrome based on actual patient data.
Alagille Syndrome is Caused by Mutations in Human Jagged1, Which Encodes A Ligand for Notch1

Linheng Li,Ian D. Krantz,Yu Deng,Anna Genin,Amy B. Banta,Colin C. Collins,Ming Qi,Barbara J. Trask,Wen Lin Kuo,Joanne Cochran,Teresa Costa,Mary Ella M. Pierpont,Elizabeth B. Rand,David A. Piccoli,Leroy Hood,Nancy B. Spinner

DOI: https://doi.org/10.1038/ng0797-243

IF: 30.8

1997-01-01

Nature Genetics

Abstract:Alagille syndrome is an autosomal dominant disorder characterized by abnormal development of liver, heart, skeleton, eye, face and, less frequently, kidney. Analyses of many patients with cytogenetic deletions or rearrangements have mapped the gene to chromosome 20p12, although deletions are found in a relatively small proportion of patients (< 7%). We have mapped the human Jagged1 gene (JAG1), encoding a ligand for the developmentally important Notch transmembrane receptor, to the Alagille syndrome critical region within 20p12. The Notch intercellular signalling pathway has been shown to mediate cell fate decisions during development in invertebrates and vertebrates. We demonstrate four distinct coding mutations in JAG1 from four Alagille syndrome families, providing evidence that it is the causal gene for Alagille syndrome. All four mutations lie within conserved regions of the gene and cause translational frameshifts, resulting in gross alterations of the protein product. Patients with cytogenetically detectable deletions including JAG1 have Alagille syndrome, supporting the hypothesis that haploinsufficiency for this gene is one of the mechanisms causing the Alagille syndrome phenotype.
Jag1 Mutation Spectrum And Origin In Chinese Children With Clinical Features Of Alagille Syndrome

Liting Li,Jibin Dong,Xiaohong Wang,Hongmei Guo,Huijun Wang,Jing Zhao,Yiling Qiu,Kuerbanjiang Abuduxikuer,Jianshe Wang

DOI: https://doi.org/10.1371/journal.pone.0130355

IF: 3.7

2015-01-01

PLoS ONE

Abstract:Alagille syndrome is an autosomal dominant disorder that results from defects in the Notch signaling pathway, which is most frequently due to JAG1 mutations. This study investigated the rate, spectrum, and origin of JAG1 mutations in 91 Chinese children presenting with at least two clinical features of Alagille syndrome (cholestasis, heart murmur, skeletal abnormalities, ocular abnormalities, characteristic facial features, and renal abnormalities). Direct sequencing and/or multiplex-ligation-dependent probe amplification were performed in these patients, and segregation analysis was performed using samples available from the parents. JAG1 disease-causing mutations were detected in 70/91 (76.9%) patients, including 29/70 (41.4%) small deletions, 6/70 (8.6%) small insertions, 16/70 (22.9%) nonsense mutations, 8/70 (11.4%) splice-site mutations, 6/70 (9.4%) missense mutations, and 5/70 (7.1%) gross deletions. Of the mutations detected, 45/62 (72.6%) were novel, and almost all were unique, with the exception of c.439C>T, c.439+1G>A, c.703C>T, c.1382_1383delAC, c.2698C>T, and c.2990C>A, which were detected in two cases each; three cases exhibited entire gene deletions. A majority (69.2%) of the point and frameshift mutations could be detected by the sequencing of eleven exons (exons 3, 5, 6, 11, 14, 16, 18, 21, and 23-25). The mutation detection rate was 50.0% (10/20) in atypical cases that only presented with two or three clinical features of Alagille syndrome. Segregation analysis revealed that 81.1% (30/37) of these mutations were de novo. In conclusion, JAG1 mutations are present in the majority of Chinese pediatric patients with clinical features of Alagille syndrome, and the mutations concentrate on different exons from other reports. Genetic study is important for the diagnosis of atypical Alagille syndrome in Chinese patients.
Case Report: Novel JAG1 Gene Mutations in Two Infants with Alagille Syndrome Characterized by Cholestasis

Yijiang Han,Kun Zhu,Hao Wu,Baohai Chen,Shuqi Hu,Dengming Lai,Jinfa Tou

DOI: https://doi.org/10.3389/fped.2022.1017647

IF: 3.569

2022-01-01

Frontiers in Pediatrics

Abstract:BackgroundInfants with Alagille syndrome (ALGS) need to be promptly differentiated from biliary atresia (BA) at an early stage. ALGS is an autosomal, dominant, multisystem disorder with variable phenotypic penetrance caused by heterozygous mutations in JAG1 or NOTCH2, which encode the Notch signaling pathway.Case presentationWe report two cases, both with cholestatic jaundice as the main manifestation, in which BA was excluded and finally diagnosed as ALGS based on characteristic facial features, serological tests, imaging, laparoscopic cholangiography, pathology and genetic findings. Both cases are novel mutant genes on chromosome 20 that have not been reported in the literature. The mutation in patient 1 was a novel heterozygous nonsense mutation (NM_000214 exon20, c.2419G > T, p.E807Ter), which was a spontaneous mutation. Followed up to 1 year and 6 months, the symptoms resolved with ursodeoxycholic acid and cholestyramine, and the jaundice has now subsided. Patient 2 was a novel heterozygous frameshift mutation (NM_000214 exon19, c.2367–2368dupTC, p.P790Lfs*31), which was inherited from his mother. This patient was followed up to 9 months and is currently awaiting liver transplantation.ConclusionBoth cholestatic infants reported combined to exclude BA, avoid Kasai portoenterostomy (KPE), and definitively diagnose ALGS. Broadening the spectrum of JAG1 gene mutations.
Novel JAG1 variants leading to Alagille syndrome in two Chinese cases

Xiufang Feng,Jiangyuan Ping,Shan Gao,Dong Han,Wenxia Song,Xiaoze Li,Yilun Tao,Lihong Wang

DOI: https://doi.org/10.1038/s41598-024-52357-0

IF: 4.6

2024-01-21

Scientific Reports

Abstract:Alagille Syndrome (ALGS) is a complex genetic disorder characterized by cholestasis, congenital cardiac anomalies, and butterfly vertebrae. The variable phenotypic expression of ALGS can lead to challenges in accurately diagnosing affected infants, potentially resulting in misdiagnoses or underdiagnoses. This study highlights novel JAG1 gene mutations in two cases of ALGS. The first case with a novel p.Pro325Leufs*87 variant was diagnosed at 2 months of age and exhibited a favorable prognosis and an unexpected manifestation of congenital hypothyroidism. Before the age of 2, the second patient was incorrectly diagnosed with liver structural abnormalities, necessitating extensive treatment. In addition, he exhibited delays in language acquisition that may have been a result of SNAP25 haploinsufficiency. The identification of ALGS remains challenging, highlighting the importance of early detection and genetic testing for effective patient management. The variant p.Pro325Leufs*87 is distinct from reported variants linked to congenital hypothyroidism in ALGS patients, thereby further confirming the clinical and genetic complexity of ALGS. This emphasizes the critical need for individualized and innovative approaches to diagnosis and medical interventions, uniquely intended to address the complexity of this syndrome.

multidisciplinary sciences
Analysis of JAG1 Gene Variant in Chinese Patients with Alagille Syndrome.

Honglian Wang,Xiaohong Wang,Qiaoli Li,Shiting Chen,Liyan Liu,Zhiyun Wei,Lei Wang,Yun Liu,Xinzhi Zhao,Lin He,Jianshe Wang,Qinghe Xing

DOI: https://doi.org/10.1016/j.gene.2012.02.038

IF: 3.913

2012-01-01

Gene

Abstract:Alagille syndrome (AGS) is an autosomal dominant disorder characterized by bile duct paucity. It can be caused by variations in the JAG1 gene encoding a protein of Notch ligand and by variations in the NOTCH2 gene encoding a Notch receptor. In this study we identified 15 different JAG1 gene variations in 17 Chinese patients, nine of which were novel alterations including c.766G > T, c.819delC, c.826delT, c.3099_3100delCA, c.1323_1326delCTGG, c.1771_1775delGTGCGinsT, c.1868delG, c. 2791_2792insA and c.866delG. These alterations were located in the extracellular domain of JAG1, in particular in the DSL and EGF-like repeat domain. All the specific variations in five inheritance cases investigated were de novo. Furthermore, no sequence variation of NOTCH2 was detected in JAG1 alteration negative patients.
Mutation Analysis of AAAS Gene in a Child with Allgrove Syndrome

Wang Kana,Ding Jingchao,Fang Yanlan,Liang Li,Wang Chunlin

DOI: https://doi.org/10.3760/cma.j.issn.1000-6699.2018.01.009

2018-01-01

Abstract:Objective To study the AAAS gene mutations in a child with autosomal recessive Allgrove syndrome. Methods Clinical data were collected and blood samples were obtained from the proband of Allgrove syndrome and her parents. Genomic DNA was extracted and sequenced by PCR amplification. Subclone sequencing was performed to validate the gene mutations. The disease-causing potentials of mutation genes were evaluated by the Mutation Taster, and the target protein tertiary structure was modelled by the Swiss Model. Results A new heterozygous insertion mutation(c. 1347_1348insG) of exon 15 in the proband was identified and firstly reported. Other two reported mutations were detected, which were the heterozygous mutation c. 688C>T in the patient and her mother, and the homozygous mutation c. 855C>T in the proband and her parents. In addition, it was confirmed that the novel compound heterozygous mutations(c. 688C>T, c. 1347_1348insG) in the AAAS gene of the proband were pathogenic mutation locus. Conclusion The heterozygous mutation(c. 1347_1348insG) of AAAS gene was firstly reported. In case of the patients being clinically misdiagnosed, related-gene detection should be performed for the patients who were diagnosed with primary adrenal insufficiency during the period of infants and young childhood.
De Novo Jag1 Gene Deletion Causes Atypical Severe Alagille Syndrome In A Chinese Child

Weiyuan Fang,Yi Lu,Kuerbanjiang Abuduxikuer,Bingbing Wu,Jianshe Wang,Xinbao Xie

2017-01-01

Abstract:Alagille syndrome (ALGS) is a multisystem autosomal dominant disorder caused by defects in the Notch signaling pathway. The classical criteria for ALGS diagnosis include bile duct paucity on liver biopsy in association with three of the following: Cholestasis, congenital heart disease, vertebral abnormalities, characteristic facial features, and posterior embryotoxon. However, the diagnosis is very difficult in an atypical case. Molecular confirmation of ALGS diagnosis is valuable. Here we report an atypical severe ALGS case with de novo JAG1 gene deletion. A 2-month-old Chinese boy presented with cholestasis and was initially referred to our hospital. Biliary atresia (BA), progressive familial intrahepatic cholestasis, ALGS, and other conditions with cholestasis were suspected. BA was ruled out by Omnipaque imaging through peritoneoscopy. The etiology of the child's cholestasis was unclear after liver biopsy, Sanger sequencing of the JAG1 gene, and next-generation sequencing of a panel of 41 genes known to cause genetic cholestasis disorders in children. The child's ALGS was eventually diagnosed through multiplex-ligation-dependent probe amplification dosage analysis. Heterozygosis JAG1 gene deletion was found in the child's JAG1 gene. The child died because of liver failure when he was 9 months old, although he underwent adequate treatment. We concluded that even though the child had no other typical ALGS manifestation, an infant with cholestasis should always prompt pediatricians to exclude ALGS with different genetic testing methods. And the heterozygosis De Novo JAG1 gene deletion can lead to severe liver disease and cause liver failure and death at an early age.
Hepatoblastoma in a cirrhotic child with Alagille syndrome

Sumit Agrawal,Bishnupriya Sahoo,Karunesh Kumar,Smita Malhotra,Anupam Sibal

DOI: https://doi.org/10.1136/bcr-2022-253080

2024-02-27

Abstract:Alagille syndrome (AGS) is a genetic disorder due to mutations in the JAGGED 1 or NOTCH 2 genes leading to multisystemic manifestations. Though these patients are at risk of developing various liver tumours, no cases of hepatoblastoma among young children with cirrhosis in AGS have been reported. We report a male toddler, with cirrhosis due to AGS who developed a hepatoblastoma. He underwent a liver transplant for decompensated chronic liver disease with marked pruritus, very high alpha-fetoprotein levels and malignant liver lesions on positron emission tomography CT. His explant histology revealed a paucity of bile ducts and liver lesions turned out to be hepatoblastoma for which he received postoperative chemotherapy. The genetic testing sent before transplantation confirmed the clinical diagnosis of AGS. Hepatoblastoma should be suspected in any child with AGS presenting with a right upper quadrant mass even in the setting of chronic liver disease.
Digenetic Inheritance of SLC12A3 and CLCNKB Genes in a Chinese Girl with Gitelman Syndrome

Yuanmei Kong,Ke Xu,Ke Yuan,Jianfang Zhu,Weiyue Gu,Li Liang,Chunlin Wang

DOI: https://doi.org/10.1186/s12887-019-1498-3

2019-01-01

BMC Pediatrics

Abstract:Gitelman syndrome (GS) is an autosomal recessive disorder and mild variant of classic Bartter syndrome. The latter is caused by defects in the genes CLCNKB and/or CLCNKA (chloride voltage-gated channel Ka and Kb). Patients with GS usually have loss-of-function mutations in SLC12A3. No patient has been reported with compound heterozygous mutations in these genes. We report a girl with GS with a paternally inherited heterozygous mutation in SLC12A3, and maternally inherited heterozygous variants in both CLCNKB and CLCNKA. In this report, we reported a female patient (8 y and 10 mo) who had growth retardation (111.8 cm, − 1.62 standard deviation height for age) and normal blood pressure, with persistent hypokalemia, hypomagnesemia, hypocalciuria, hypochloremic alkalosis, and elevated levels of plasma renin and aldosterone. Her younger brother, father, and paternal grandmother all had histories of mild low levels of plasma potassium (3.0–3.5 mmol/L), which were rectified by potassium-rich foods. The genomic DNA of the patient, younger brother, parents, and grandparents were screened for gene variations and pedigree analysis using trio whole exome sequencing (WES). The candidate variants were validated by Sanger sequencing. Protein-protein interaction analysis utilized the following databases: Biogrid, MINT, HPRD, STRING, IntAct, iRefIndex, and ppiTrim. The trio WES screening showed that the patient has paternally inherited SLC12A3 p.N359K, and maternally inherited CLCNKB p.L94I. The paternal grandmother and younger brother are both carriers of SLC12A3 p.N359K. According to the STRING database, SLC12A3 and CLCNKB proteins may interact or coexpress with proteins associated with GS. Based on clinical phenotypes, genetic evidence of the pedigree, and previous reported studies, this case of GS indicates a digenetic inheritance of SLC12A3 and CLCNKB that resulted in renal tubular dysfunction perhaps, due to a genetic double-hit mechanism. The putative pathogenicity of the CLCNKB p.L94I variant requires confirmation.
Clinical and Pathological Features of Alpers Syndrome and Gene Mutational Analysis

BAO Xin-hua,WU Ye,XIONG Hui,ZHANG Yue-hua,JIANG Yu-wu,QIN Jiong,YUAN Yun,LIN Q,WU Xi-ru

DOI: https://doi.org/10.3969/j.issn.1003-515X.2008.24.015

2008-01-01

Abstract:Objective To explore the pathogenic cause of child with intractable epilepsy and the characteristic of Alpers syndrome.Methods The clinical manifestation of 1 case was observed,and electromyogram,video-electroencephalogram,magnetic resonance imaging lumbar puncture and biopsies of muscle,peripheral nerve and brain were performed.Gene mutational analysis of mtDNA,deoxyguanosine kinase and polymerase gamma 1(POLG1)were conducted.Results The clinical manifestation of the patient included refractory seizures,acute liver failure after exposure to valproic acid,cortical blindness and psychomotor regression.The cerebrospinal fluid(CSF)was acellular but the protein concentration increased.The immunological studies of CSF showed that oligo-clone bands were positive,IgG synthesis rate and IgG index increased.Series of electroencephalogram showed slow activity and almost continuous spike wave over the central,parietal and occipital regions of both hemispheres.The brain MRI showed flair signals in hemioval central white matter,cerebellar white matter and occipital region.Diffused brain atrophy was revealed later.Gastrocnemius muscle biopsy was unremarkable.Sural nerve biopsy showed damaged axon and myelin.Left occipital lobe biopsy showed astrocytosis,neuronal loss and sponginess in the cortex and partial demyelination,gliosis,and vacuolization in white matter screening of mtDNA common mutations and coding exons of dexyguanosine kinase gene were negative.Two novel heterozygous missense variants,c.248T>C(p.L83P),c.2662G>A(p.G888S)were detected in POLG1 gene.Sequence analysis of parental blood DNA revealed that her father carried L83P and her mother carried G888S.Conclusions The characteristics of clinical manifestation,electrophysiology,pathology and POLG1 gene mutation of the patient were highly consistent with Alpers syndrome.The prominent white matter change and increased immunological factors in CSF were first reported in Alpers syndrome.Alpers syndrome should be considered for those patients whose liver function were severely impaired after exposure to valproic acid.
JAGGED1 gene variations in Chinese twin sisters with Alagille syndrome

Xinbao Xie,Yi Lu,Xiaohong Wang,Bingbing Wu,Hui Yu

2015-07-01

Abstract:Variations in the JAGGED1 gene have been found to cause Alagille syndrome. Nevertheless, no particular hotspots in the gene have been found; any part of the entire coding regions for JAGGED1 may be involved. Twin sisters with jaundice visited our hospital and were diagnosed with Alagille syndrome. The gene variations in their JAGGED1 coding sequences were evaluated by complementary DNA sequencing. The 12-month-old twin sisters have broad foreheads, deep-set eyes, pointed chins, and triangular faces with jaundice. Clinical testing showed the presence of posterior embryotoxon, butterfly vertebrae, and atrial septal defect. Biochemical indexes showed cholestasis and liver damage. Three conserved variations were identified within exons 22 (c.2612C>G), 24 (c.2957T>A), and 26 (c.3417T>C) in the JAGGED1 coding sequence. The predicted consequences for c.2612C>G, c.2957T>A, and c.3417T>C were p.Pro871Arg, p.Leu986*, and p.Tyr1139=, respectively. The T to A change in the JAGGED1 coding sequence at 2957 will generate a stop codon and might lead to deletion of amino acid 233 at the C terminal of the JAGGED1 protein. Our data suggest that gene variations of c.2612C>G, c.2957T>A, and c.3417T>C, especially c.2957T>A, might have contributed to the pathogenesis of Alagille syndrome in these Chinese twin sisters and provided new gene evidences for Alagille syndrome.
Management of Patients with Alagille Syndrome Undergoing Living Donor Liver Transplantation: A Report of 2 Cases

Odai Jamaan Alqahtani,Riaz Nazeer Ahmad,Abdullah Bakr Abolkhair,Aljazi Dhari Alrashid

DOI: https://doi.org/10.12659/AJCR.936513

2022-08-03

Abstract:BACKGROUND Alagille syndrome (AGS) is a rare genetic disease characterized by 5 typical features: peculiar facial anomaly, posterior embryotoxon, chronic cholestasis, butterfly-like vertebral-arch defects, and cardiovascular malformations. AGS in a liver transplant setting is particularly rare in Saudi Arabia. This case report presents successful anesthetic management in AGS patients during liver transplantation surgery. CASE REPORT We present here 2 patients with AGS who underwent liver transplantation surgery. Case 1 describes a 3-year-old boy who was diagnosed with AGS at the age of 2 weeks, manifesting as a prominent forehead, deep-set eyes, pointed chin, and butterfly-shaped vertebrae, along with coarctation of the aorta, peripheral branch pulmonary artery stenosis, direct hyperbilirubinemia, cholestasis, and G6PD deficiency. Case 2 describes a 12-year-old girl, known to have AGS, who presented with decompensated liver disease, portal hypertension, splenomegaly, hypersplenism, and portal vein thrombosis, as well as the other dysmorphic features of AGS, such as a prominent forehead, deep-set eyes, pointed chin, and butterfly-shaped vertebrae. The anesthetic management of the 2 patients started from the perioperative period with careful assessment and optimization of the cardiovascular system, intraoperative maintenance of stable hemodynamics, the use of inhaled nitric oxide when clinically indicated (used in case 1), and the use of goal-directed management of fluid as well as blood and blood products. These all played a major role in the successful management of anesthesia for these patients. CONCLUSIONS The important features of successful anesthetic management included thorough preoperative cardiovascular system evaluation and intra-operative maintenance of normal temperature, ionized calcium, pH, hemoglobin, and stable hemodynamics.

Nursing of children patients with Alagille syndrome

Advances in the Research of Molecular Genetics of Alagille Syndrome

Clinical, pathological and genetic characteristics of 17 unrelated children with Alagille Syndrome

A Chinese Girl Molecularly Diagnosed with Alagille Syndrome.

Targeted Sequencing and RNA Assay Reveal a Noncanonical JAG1 Splicing Variant Causing Alagille Syndrome.

Clinical Analysis of Pediatric Liver Transplantation for Alagille Syndrome

Clinical and pathological characteristics of Alagille syndrome in Chinese children

[Identification of a Novel JAG1 Mutation in a Family Affected by Alagille Syndrome].

The Curious Case of Alagille Syndrome: A Case Report With NANDA-I Classification, NIC, and NOC Linkage to the Patient Care Plan

Alagille Syndrome is Caused by Mutations in Human Jagged1, Which Encodes A Ligand for Notch1

Jag1 Mutation Spectrum And Origin In Chinese Children With Clinical Features Of Alagille Syndrome

Case Report: Novel JAG1 Gene Mutations in Two Infants with Alagille Syndrome Characterized by Cholestasis

Novel JAG1 variants leading to Alagille syndrome in two Chinese cases

Analysis of JAG1 Gene Variant in Chinese Patients with Alagille Syndrome.

Mutation Analysis of AAAS Gene in a Child with Allgrove Syndrome

De Novo Jag1 Gene Deletion Causes Atypical Severe Alagille Syndrome In A Chinese Child

Hepatoblastoma in a cirrhotic child with Alagille syndrome

Digenetic Inheritance of SLC12A3 and CLCNKB Genes in a Chinese Girl with Gitelman Syndrome

Clinical and Pathological Features of Alpers Syndrome and Gene Mutational Analysis

JAGGED1 gene variations in Chinese twin sisters with Alagille syndrome

Management of Patients with Alagille Syndrome Undergoing Living Donor Liver Transplantation: A Report of 2 Cases